Top up while you can at these discounted prices. Others will want a percentage interest in RAP as its technology is released.
Additional offers may materialise in coming weeks as other pharmaceutical companies want a slice of the next phase in COVID testing.
The technology should be available to multiple parties to profit from.
Shareholder Registry, page-20
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #